Profitelligence Profitelligence · Filing Ledger Search all insiders →

Insider Profile · SEC Form 4 Activity · Trailing 90 Days

Hansen Gwenn

Over the trailing 90 days, Hansen Gwenn (Other Officer at Nurix Therapeutics, Inc.) sold $198K of stock in NRIX, per 8 SEC Form 4 transactions.

Role
Other Officer
Companies
NRIX
Window
Trailing 90 days · 8 transactions · CIK 1817160
Net activity
−$198K ($0 bought · $198K sold)

By Company (Trailing 90 Days)

SymbolCompanyTxnsBoughtSoldNet
NRIXNurix Therapeutics, Inc.8$198K−$198K

Transactions (8)

DateSymbolTypeSharesValueDescription
2026-07-30NRIXSell2.9K$0Exercise or conversion of derivative security
2026-07-30NRIXSell3.6K$0Exercise or conversion of derivative security
2026-07-30NRIXSell3.8K$90KOpen market or private sale
2026-07-30NRIXBuy3.6K$0Exercise or conversion of derivative security
2026-07-30NRIXBuy2.9K$0Exercise or conversion of derivative security
2026-07-30NRIXBuy3.8K$0Exercise or conversion of derivative security
2026-07-30NRIXSell3.8K$0Exercise or conversion of derivative security
2026-06-25NRIXSell5.4K$108KOpen market or private sale

Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.

Follow Hansen's next move

Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.

Start free